Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium in tardive dyskinesia

G M Simpson, M H Branchey, J H Lee

    Pharmakopsychiatrie, Neuro-Psychopharmakologie
    |March 1, 1976
    PubMed
    Summary

    Lithium treatment showed no significant benefit for elderly patients with tardive dyskinesia in two trials. Neuroleptic medications demonstrated a more substantial effect on symptom suppression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Abscisic acid associated with wilting in dwarf and tall Pisum sativum.

    Planta·2014
    Same author

    Considerations in choosing an antidepressant.

    Psychiatric services (Washington, D.C.)·2001
    Same author

    Psychopharmacology: rational and irrational polypharmacy.

    Psychiatric services (Washington, D.C.)·2001
    Same author

    The apparent effects of ziprasidone on plasma lipids and glucose.

    The Journal of clinical psychiatry·2001
    Same author

    Cardiac effects of antipsychotic medications.

    Psychiatric services (Washington, D.C.)·2001
    Same author

    Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation.

    The Journal of clinical psychiatry·2001

    Area of Science:

    • Neurology
    • Geriatrics
    • Psychiatry

    Background:

    • Tardive dyskinesia is a persistent neurological disorder often associated with long-term neuroleptic use.
    • Elderly patients may present unique challenges in managing tardive dyskinesia due to comorbidities and polypharmacy.

    Purpose of the Study:

    • To evaluate the efficacy of lithium in treating tardive dyskinesia in an elderly population.
    • To compare lithium's effects with ongoing neuroleptic treatment versus its effects after neuroleptic discontinuation.

    Main Methods:

    • A single-blind trial was conducted with continued neuroleptic medication.
    • A placebo-controlled, double-blind trial was performed after discontinuing neuroleptic medication.
    • Both trials focused on elderly patients diagnosed with tardive dyskinesia.

    Main Results:

    • Lithium treatment did not demonstrate a significant therapeutic effect in either trial.
    • The observed effects of lithium were minimal compared to the suppressive impact of neuroleptic drugs.
    • Neuroleptic medications exhibited a markedly more pronounced effect on symptom suppression.

    Conclusions:

    • Lithium is not an effective treatment for tardive dyskinesia in the elderly population studied.
    • The efficacy of neuroleptics in suppressing tardive dyskinesia symptoms is significantly greater than that of lithium.
    • Symptom severity and chronicity may influence treatment outcomes in tardive dyskinesia.

    Related Experiment Videos